ResearcherGITAM UniversityActive in the last 2 years
Rama Rao Malla
Matched on ORCID iD 0000-0003-2448-1681; OpenAlex author ID A5071882369. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2019: 2 papers · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 5
- Pancreatic cancer exosomes: Their role in drug resistance and immunomodulation. Co-author DOI 10.1016/j.cytogfr.2025.10.004↗
- Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges. First author DOI 10.1016/j.semcancer.2023.11.002↗
- Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1. First author DOI 10.1016/j.semcancer.2021.11.003↗
- Cytogenetic, Molecular, and Translational Applications in Pancreatic Ductal Adenocarcinoma: Current Evidence and Future Concepts. Co-author DOI 10.1615/critrevoncog.2019030929↗
- Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer. Last author DOI 10.1615/critrevoncog.2019031202↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ganji Purnachandra Nagaraju · 3 shared papers, 2022–2025 · strength 0.89
- Paper Pancreatic cancer exosomes: Their role in drug resistance and immunomodulation. DOI 10.1016/j.cytogfr.2025.10.004↗
- Paper Obesity associated pancreatic ductal adenocarcinoma: Therapeutic challenges. DOI 10.1016/j.semcancer.2023.11.002↗
- Paper Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1. DOI 10.1016/j.semcancer.2021.11.003↗
- Mundla Srilatha · 1 shared paper, 2023 · strength 0.24
- Jeremy B. Foote · 1 shared paper, 2023 · strength 0.24
- Riyaz M. Basha · 1 shared paper, 2022 · strength 0.22
- Ion G. Motofei · 1 shared paper, 2022 · strength 0.22
- Seema Kumari · 1 shared paper, 2019 · strength 0.20
- L. Srinivas · 1 shared paper, 2019 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.